FDA-approved cord blood therapy demonstrates faster recovery and high survival rates. A clinical trial led by the National Institutes of Health (NIH) reported that an experimental stem cell…
Read MoreImmunotherapy
FDA Approves Immunotherapy Treatment for Adult Respiratory Papillomatosis
Final reports from Precigen showed long-term effectiveness of the injections with reduced side effects. The Food and Drug Administration (FDA) has approved a drug manufactured by Precigen to…
Read More
FDA Approves First TCR Gene Therapy for Synovial Sarcoma
Tecelra treats rare cancer through immunotherapy. The U.S. Food and Drug Administration (FDA) has approved Tecelra (afamitresgene autoleucel), a gene therapy for adults with unresectable or metastatic synovial…
Read More